This activity is supported
by an educational grant from
Otsuka Pharmaceuticals.
This activity is sponsored by
This event is not part of the official ACC Annual Scientific Session and/or i2 Summit 2007 as planned by the Annual Scientific Session Program Committee (ASSPC) and/or the i2 Summit Program Committee.
| 5:30-6:00 AM: | Registration and Breakfast |
| 6:00-6:05 AM: | Welcome and Introduction Barry H. Greenberg, MD |
| 6:05-6:15 AM: | The Pathophysiology of Acute Heart Failure Syndromes Barry H. Greenberg, MD |
| 6:15-6:30 AM: | The Role of Congestion and Hyponatremia in Worsening Patient Outcomes Douglas L. Mann, MD |
| 6:30-6:45 AM: | Managing Fluid Overload in Heart Failure James E. Udelson, MD |
| 6:45-7:00 AM: | Questions and Answers Chair and Faculty |
After completing this session, participants should be able to:
- Analyze the pathophysiologic mechanisms leading to acute heart failure syndromes
- Explain how congestion and hyponatremia contribute to worsening outcomes in patients with heart failure
- Describe the clinical applications and limitations of currently available therapies for patients with decompensated heart failure
- Evaluate the potential role of vasopressin receptor antagonists as a new strategy for fluid and electrolyte management in heart failure
This educational activity has been developed for cardiologists and other health care professionals who treat patients with heart failure.
INNOVIA Education Institute, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
INNOVIA Education Institute designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
